Valuation : Viatris Inc.

Market Cap 19.1B 16.48B 15.52B 14.14B 26.44B 1,804B 26.63B 184B 71.32B 923B 71.73B 70.16B 3,030B P/E 2026 *
79x
P/E 2027 * 31.4x
Enterprise Value 31.17B 26.89B 25.33B 23.08B 43.13B 2,944B 43.46B 300B 116B 1,505B 117B 114B 4,945B EV / Sales 2026 *
2.11x
EV / Sales 2027 * 2.01x
Free-Float
91.44%
Yield 2026 *
3.06%
Yield 2027 * 3.14%
1 day+2.07%
1 week+1.07%
Current month+3.15%
1 month-3.40%
3 months+8.54%
6 months+8.47%
Current year+36.79%
1 week 16.12
Extreme 16.12
17.1
1 month 15.88
Extreme 15.88
18.39
Current year 12.19
Extreme 12.19
18.39
1 year 9.42
Extreme 9.425
18.39
3 years 6.85
Extreme 6.85
18.39
5 years 6.85
Extreme 6.85
18.39
10 years 6.85
Extreme 6.85
47.82
Manager TitleAgeSince
Chief Executive Officer 63 01/04/2023
Director of Finance/CFO 59 08/05/2026
Chief Tech/Sci/R&D Officer - 15/12/2023
Director TitleAgeSince
Director/Board Member 78 16/11/2020
Director/Board Member 78 16/11/2020
Director/Board Member 62 16/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
8/15/26 A Exercice

Chief Administrative Officer

63,631 0.0054%
6/30/26 A Free

Director

2,756 0.0002%
6/30/26 A Free

Director

2,362 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+2.13%+1.07%+61.27%+60.36% 19.1B
+0.08%-2.47%+57.79%+107.83% 1,034B
+1.27%+1.81%+54.38%+71.08% 654B
-0.21%-1.43%+22.28%+77.36% 459B
+0.49%-5.19%+33.28%+35.53% 343B
+0.27%+3.26%+29.76%+47.50% 307B
+0.12%-2.11%+0.60%+12.03% 251B
+0.04%-0.48%+52.73%+72.52% 237B
+2.64%-1.08%-15.85%-53.97% 202B
-0.36%+0.93%+32.61%+98.87% 186B
Average +0.64%-2.65%+32.89%+52.91% 369.07B
Weighted average by Cap. +0.43%-3.30%+38.68%+67.49%

Financials

2026 *2027 *
Net sales 14.78B 12.75B 12.01B 10.95B 20.46B 1,396B 20.61B 142B 55.2B 714B 55.51B 54.29B 2,345B 15.03B 12.97B 12.21B 11.13B 20.8B 1,420B 20.96B 145B 56.12B 726B 56.43B 55.2B 2,384B
Net income -27.26M -23.52M -22.15M -20.18M -37.72M -2.57B -38.01M -262M -102M -1.32B -102M -100M -4.32B 340M 293M 276M 252M 470M 32.11B 474M 3.27B 1.27B 16.41B 1.28B 1.25B 53.92B
Net Debt 12.07B 10.41B 9.81B 8.93B 16.7B 1,140B 16.82B 116B 45.05B 583B 45.31B 44.32B 1,914B 11.08B 9.56B 9B 8.2B 15.33B 1,047B 15.45B 107B 41.37B 535B 41.6B 40.69B 1,758B
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.
Employees
30,000
Date Price Change Volume
02/09/26 $17.03 +2.41% 2,350,105
01/09/26 $16.63 +0.73% 6,527,492
31/08/26 $16.51 +1.04% 12,669,710
28/08/26 $16.34 -3.26% 6,218,655
27/08/26 $16.89 +0.24% 6,464,665
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
16.63USD
Average target price
18.50USD
Spread / Average Target
+11.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VTRS Stock